Abstract
p21-Activated protein kinase 2 (PAK-2) has both anti- and pro-apoptotic functions depending on its mechanism of activation. Activation of full-length PAK-2 by the monomeric GTPases Cdc42 or Rac stimulates cell survival, whereas caspase activation of PAK-2 to the PAK-2p34 fragment is involved in the apoptotic response. In this study we use functional knockout of PAK-2 and gene replacement with the caspase cleavage-deficient PAK-2D212N mutant to differentiate the biological functions of full-length PAK-2 and caspase-activated PAK-2p34. Knockout of PAK-2 results in embryonic lethality at early stages before organ development, whereas replacement with the caspase cleavage-deficient PAK-2D212N results in viable and healthy mice, indicating that early embryonic lethality is caused by deficiency of full-length PAK-2 rather than lack of caspase activation to the PAK-2p34 fragment. However, deficiency of caspase activation of PAK-2 decreased spontaneous cell death of primary mouse embryonic fibroblasts and increased cell growth at high cell density. In contrast, stress-induced cell death by treatment with the anti-cancer drug cisplatin was not reduced by deficiency of caspase activation of PAK-2, but switched from an apoptotic to a nonapoptotic, caspase-independent mechanism. Homozygous PAK-2D212N primary mouse embryonic fibroblasts that lack the ability to generate the proapoptotic PAK-2p34 show less activation of the effector caspase 3, 6, and 7, indicating that caspase activation of PAK-2 amplifies the apoptotic response through a positive feedback loop resulting in more activation of effector caspases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abo A, Qu J, Cammarano MS, Dan C, Fritsch A, Baud V, Belisle B, Minden A (1998) PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J 17:6527–6540
Allen JD, Jaffer ZM, Park S-J, Burgin S, Hofmann C, Sells MA, Chen S, Derr-Yellin E, Michels EG, McDaniel A, Bessler WK, Ingram DA, Atkinson SJ, Travers JB, Chernoff J, Clapp DW (2009) p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics. Blood 113:2695–2705
Arias-Romero LE, Chernoff J (2008) A tale of two Paks. Biol Cell 100:97–108
Bagrodia S, Taylor SJ, Creasy CL, Chernoff J, Cerione RA (1995) Identification of a mouse p21Cdc42/Rac activated kinase. J Biol Chem 270:22731–22737
Bokoch GM (2003) Biology of the p21-activated kinases. Annu Rev Biochem 72:743–781
Dan C, Nath N, Liberto M, Minden A (2002) PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells. Mol Cell Biol 22:567–577
Fischer U, Stroh C, Schulze-Osthoff K (2006) Unique and overlapping substrate specificities of caspase-8 and caspase-10. Oncogene 25:152–159
Gonzalez VM, Fuertes MA, Alonso C, Perez JM (2001) Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol 59:657–663
Hofmann C, Shepelev M, Chernoff J (2004) The genetics of Pak. J Cell Sci 117:4343–4354
Jakobi R, Traugh JA (1992) Characterization of the phosphotransferase domain of casein kinase II by site-directed mutagenesis and expression in Escherichia coli. J Biol Chem 267:23894–23902
Jakobi R, Chen CJ, Tuazon PT, Traugh JA (1996) Molecular cloning and sequencing of the cytostatic G protein-activated protein kinase PAK I. J Biol Chem 271:6206–6211
Jakobi R, Moertl E, Koeppel MA (2001) p21-activated protein kinase γ-PAK suppresses programmed cell death of BALB3T3 fibroblasts. J Biol Chem 276:16624–16634
Jakobi R, McCarthy CC, Koeppel MA, Stringer DK (2003) Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation. J Biol Chem 278:38675–38685
Kissil JL, Johnson KC, Eckman MS, Jacks T (2002) Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization. J Biol Chem 277:10394–10399
Knaus UG, Morris S, Dong HJ, Chernoff J, Bokoch GM (1995) Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors. Science 269:221–223
Koeppel MA, McCarthy CC, Moertl E, Jakobi R (2004) Identification and characterization of PS-GAP as a novel regulator of caspase-activated PAK-2. J Biol Chem 279:53653–53664
Kumar R, Gururaj AE, Barnes CJ (2006) p21-activated kinases in cancer. Nat Rev Cancer 6:459–471
Lee N, MacDonald H, Reinhard C, Halenbeck R, Roulston A, Shi T, Williams LT (1997) Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis. Proc Natl Acad Sci USA 94:13642–13647
Li X, Minden A (2003) Targeted disruption of the gene for the PAK5 kinase in mice. Mol Cell Biol 23:7134–7142
Ma QL, Yang F, Calon F, Ubeda OJ, Hansen JE, Weisbart RH, Beech W, Frautschy SA, Cole GM (2008) p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis. J Biol Chem 283:14132–14143
Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L (1994) A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367:40–46
Manser E, Chong C, Zhao ZS, Leung T, Michael G, Hall C, Lim L (1995) Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family. J Biol Chem 270:25070–25078
Marlin JW, Eaton A, Montano GT, Chang YW, Jakobi R (2009) Elevated p21-activated kinase 2 activity results in anchorage-independent growth and resistance to anticancer drug-induced cell death. Neoplasia 11:286–297
Marlin JW, Chang YW, Jakobi R (2010) Caspase activation of p21-activated kinase 2 occurs during cisplatin-induced apoptosis of SH-SY5Y neuroblastoma cells and in SH-SY5Y cell culture models of Alzheimer’s and Parkinson’s disease. J Cell Death 3:23–32
Martin GA, Bollag G, McCormick F, Abo A (1995) A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20. EMBO J 14:4385
Mira JP, Benard V, Groffen J, Sanders LC, Knaus UG (2000) Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway. Proc Natl Acad Sci USA 97:185–189
Nguyen TV, Galvan V, Huang W, Banwait S, Tang H, Zhang J, Bredesen DE (2008) Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. J Neurochem 104:1065–1080
Qu J, Li X, Novitch BG, Zheng Y, Kohn M, Xie JM, Kozinn S, Bronson R, Beg AA, Minden A (2003) PAK4 kinase is essential for embryonic viability and for proper neuronal development. Mol Cell Biol 23:7122–7133
Rudel T, Bokoch GM (1997) Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276:1571–1574
Rudel T, Zenke FT, Chuang TH, Bokoch GM (1998) p21-activated kinase (PAK) is required for Fas-induced JNK activation in Jurkat cells. J Immunol 160:7–11
Sarkar G, Sommer SS (1990) The “megaprimer” method of site-directed mutagenesis. Biotechniques 8:404–407
Schlesinger TK, Bonvin C, Jarpe MB, Fanger GR, Cardinaux JR, Johnson GL, Widmann C (2002) Apoptosis stimulated by the 91-kDa caspase cleavage MEKK1 fragment requires translocation to soluble cellular compartments. J Biol Chem 277:10283–10291
Spector DL, Goldman RD, Leinwand LA (1998) Cells: A laboratory manual. CSHL Press, Cold Spring Harbor
Teo M, Manser E, Lim L (1995) Identification and molecular cloning of a p21cdc42/rac1-activated serine/threonine kinase that is rapidly activated by thrombin in platelets. J Biol Chem 270:26690–26697
Ura S, Masuyama N, Graves JD, Gotoh Y (2001) Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation. Proc Natl Acad Sci USA 98:10148–10153
Walter BN, Huang Z, Jakobi R, Tuazon PT, Alnemri ES, Litwack G, Traugh JA (1998) Cleavage and activation of p21-activated protein kinase γ-PAK by CPP32 (caspase 3). Effects of autophosphorylation on activity. J Biol Chem 273:28733–28739
Yang F, Li X, Sharma M, Zarnegar M, Lim B, Sun Z (2001) Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6. J Biol Chem 276:15345–15353
Zhao L, Ma QL, Calon F, Harris-White ME, Yang F, Lim GP, Morihara T, Ubeda OJ, Ambegaokar S, Hansen JE, Weisbart RH, Teter B, Frautschy SA, Cole GM (2006) Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat Neurosci 9:234–242
Acknowledgment
The authors thank Jonathan Chernoff for the PAK-2 BAC clone 21411, Richard Palmiter for the 4523G9 vector, and Andras Nagy for R1 mouse embryonic stem cells. This work was supported by a Kansas City Area Life Sciences Institute (KCALSI) Research Development Grant to R.J. and W.X. and NIH/NCI 5P30CA044579-19S49016 grant to W.X.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Marlin, J.W., Chang, YW.E., Ober, M. et al. Functional PAK-2 knockout and replacement with a caspase cleavage-deficient mutant in mice reveals differential requirements of full-length PAK-2 and caspase-activated PAK-2p34. Mamm Genome 22, 306–317 (2011). https://doi.org/10.1007/s00335-011-9326-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-011-9326-6